Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of breastfeeding after maternal tenofovir therapy in chronic hepatitis B
ChiCTR2100044877Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Bone mineral density. Started Jul 2019; status: recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2100044877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044877.